Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial-Reference-Cited by-同舟云学术

Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial

Published:2016-06-19 Issue:8 Volume:31 Page:1713-1722
ISSN:0268-1161
Container-title:Human Reproduction
language:en
Short-container-title:Hum. Reprod.

Author:

Schultze-Mosgau M.-H.,Waellnitz K.,Nave R.,Klein S.,Kraetzschmar J.,Rautenberg T.,Schmitz H.,Rohde B.

Funder

Bayer Pharma AG

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Reference41 articles.

1. Aromatase inhibition for refractory endometriosis-related chronic pelvic pain

2. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study

3. Practice Bulletin No. 114: Management of Endometriosis

4. Treatment of pelvic pain associated with endometriosis: a committee opinion

5. Anastrazole and oral contraceptives: a novel treatment for endometriosis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy, Pharmacokinetics, and Safety of the Available Medical Options in the Treatment of Endometriosis-Related Pelvic Pain: A Scoping Review;Pharmaceuticals;2023-09-18

2. Aromatase inhibitors in the pharmacotherapy of endometriosis;Expert Opinion on Pharmacotherapy;2023-05-03

3. A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date;Drug Design, Development and Therapy;2023-05

4. Endometriosis, the Silent Disease: Molecular Targets, Active Principles, and Drug Delivery Systems;Helvetica Chimica Acta;2022-12-12

5. Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism;Frontiers in Endocrinology;2022-09-20